Reactions Weekly

, Volume 1695, Issue 1, pp 36–36 | Cite as

Anti CD19 CAR transduced T cells

Cytokine release syndrome: case report
Case report
  • 14 Downloads

Reference

  1. Tang X, et al. MVP combined with FC as lymphocyte-depleting chemotherapy before car-t treatment can reduce the incidence of severe cytokine release syndrome for relapsed/refractory all patients with high tumour burden. Blood 130 (Suppl. 1): Dec 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/5041?sso-checked=true [abstract] - China

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations